Evidence-based novel therapies in HCM
Michelle Michels, MD
Optimal pharmacological management of HCM by clinical manifestations
Pablo Garcia-Pavia, MD, PhD
Staging therapy in hypertrophic cardiomyopathy patients with heart failure: New insights
Aleš Linhart, MD, PhD
Recognizing and diagnosing heart failure in patients with HCM
Breaking barriers in guideline-based RAASi therapy: Solving issues with hyperkalemia
Shelley Zieroth, MD
Mikhail Kosiborod, MD
Aaron Wong, MD
Continuing foundational therapy in symptomatic HF: the key role of RAASi-based therapy
What to do if potassium levels increase in HF?
Practical experience and model for optimizing RAASi-based therapy in HF
Hypertrophic cardiomyopathy & heart failure: exploring new options
Rudolf de Boer, MD, PhD
Mariana Brandão, MD
Iacopo Olivotto, MD
Managing patients with HCM and HF: what’s new in the therapeutic landscape?
HCM and heart failure: is your patient at risk?
Recognizing HCM and HF: making the diagnosis
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.